Document is current
Any future updates will be listed below
-
Authors
Reimão-Pinto, Madalena M https://orcid.org/0000-0002-3704-650X
Behrens, Andrew https://orcid.org/0000-0001-9759-6207
Forcelloni, Sergio https://orcid.org/0000-0002-1831-2569
Fröhlich, Klemens https://orcid.org/0000-0003-1445-0750
Kaya, Selay https://orcid.org/0009-0009-2982-7590
Nedialkova, Danny D https://orcid.org/0000-0001-8598-6021
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 1035,Project number 201302640,Project B14)
European Molecular Biology Organization (YIP 4833)
European Molecular Biology Organization (ALTF 691-2019)
EC | Horizon 2020 Framework Programme (H2020-MSCA-IF-2019 No. 898218)
Alexander von Humboldt-Stiftung
EC | ERC | HORIZON EUROPE European Research Council (803825-TransTempoFold)
- License Information
-
More Information
Article History
Received: 7 March 2024
Revised: 23 September 2024
Accepted: 27 September 2024
First Online: 14 October 2024
Disclosure and competing interests statement
: AB and DDN are inventors on a patent application filed by the Max Planck Society pertaining to the mim-tRNAseq technology. The other authors declare no competing interests.
